Document Detail

Academic detailing improves identification and reporting of adverse drug events.
MedLine Citation:
PMID:  10427579     Owner:  NLM     Status:  MEDLINE    
In a prospective, crossover study, we assessed the impact of a clinical pharmacist on identification and reporting of adverse drug events (ADEs) in hospitalized patients. The study was conducted on four units of a medical ward of a university hospital, with two units serving as test, the other two as control units. After 12 months, test and control units were switched. In the test units, a pharmacist participated in daily ward rounds, solicited additional information from physicians and nurses, and reviewed the charts of all patients. In control units, information on ADEs was based solely on voluntary reports from physicians and nurses. A total of 1,959 patients (941 in test, 1,018 in control units) were hospitalized during the study period. In 137 test units patients, 224 ADEs (14.6%; 95%-CI: 12.3%-16.9%) were detected (8 severe, 60 moderate, 156 mild), while 25 ADEs (1 severe, 11 moderate, 13 mild) occurring in 21 patients (2.1%; 95%-CI: 1.2%-3.0%) were reported from the control units (p < 0.0001). Of the ADEs in the test units, 51% were reported spontaneously, 39% were identified on rounds, and 10% by chart review. After changing the status of test and control units, the number of identified ADEs returned to preintervention levels. Clinical pharmacists as part of the medical care team can improve the identification of ADEs which may ultimately translate into improved quality of care.
R G Schlienger; T F Lüscher; R A Schoenenberger; W E Haefeli
Related Documents :
10317549 - Factors affecting laboratory test use and prices.
8045019 - Conceptual framework for evaluating laboratory tests: case-finding in ambulatory patients.
1439869 - The use of positron emission tomography in the clinical assessment of dementia.
19480219 - Accepted legal applications of actuarial testing and delinquency interventions: example...
3086639 - Do interns and residents order more tests than attending staff? results of a house staf...
3951079 - Feedback reduces test use in a health maintenance organization.
23694799 - Interferon-gamma release assays for the diagnosis of latent tuberculosis infection: an ...
12755289 - Regional risk of exporting cattle seropositive for bluetongue virus from the united sta...
22085589 - Regulatory assessment of in vitro skin corrosion and irritation data within the europea...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pharmacy world & science : PWS     Volume:  21     ISSN:  0928-1231     ISO Abbreviation:  Pharm World Sci     Publication Date:  1999 Jun 
Date Detail:
Created Date:  1999-09-20     Completed Date:  1999-09-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9307352     Medline TA:  Pharm World Sci     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  110-5     Citation Subset:  IM    
Department of Internal Medicine, University Hospital, Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adverse Drug Reaction Reporting Systems*
Cross-Over Studies
Middle Aged
Pharmaceutical Preparations / adverse effects*
Prospective Studies
Reg. No./Substance:
0/Pharmaceutical Preparations

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Subjective outcome measurement--a primer.
Next Document:  Asthma exacerbations during first therapy with long acting beta 2-agonists.